Back to search results

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Tuberculosis, Pulmonary

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • General Medicine & Global Health, Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Observatory, WC, South Africa

    Contact: Study coordinator (Sandra Mukasa, MD) · sandra.mukasa@uct.ac.za
    Contact: Principal Investigator (Sandra Mukasa, MD)
    Karen Wolmarans, MD (Sub-investigator)
    Fareda Jakoet-Bassier, MD (Sub-investigator)
    Ashley Taylor, MD (Sub-investigator)
Study leads

  • Friedrich Thienemann, MD

    Principal Investigator

    University of Cape Town

  • Reto Guler, PhD

    Study Chair

    University of Cape Town

View source on ClinicalTrials.gov(opens in a new tab)